MedPath

BEIJING NEUROSURGICAL INSTITUTE

BEIJING NEUROSURGICAL INSTITUTE logo
🇨🇳China
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma

Phase 1
Recruiting
Conditions
Glioblastoma Multiforme
Glioma, Malignant
Interventions
First Posted Date
2024-09-05
Last Posted Date
2024-10-31
Lead Sponsor
Beijing Neurosurgical Institute
Target Recruit Count
30
Registration Number
NCT06585527
Locations
🇨🇳

Beijing Tiantan Hospital, Beijing, Beijing, China

Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma

Phase 1
Completed
Conditions
Glioblastoma Multiforme
Gliomas, Malignant
Interventions
Biological: ON-01
Drug: ONF
First Posted Date
2024-08-20
Last Posted Date
2024-08-20
Lead Sponsor
Beijing Neurosurgical Institute
Target Recruit Count
38
Registration Number
NCT06562621
Locations
🇨🇳

Beijing Tiantan Hospital, Beijing, Beijing, China

Accelerating Motor Recovering in Patients With SMA Syndrome After Glioma Surgery by Using nrTMS

Not Applicable
Recruiting
Conditions
Supplementary Motor Area Syndrome
Motor Cortex; Lesion
Glioma
Interventions
Device: TMS stimulation sham-treatment
Device: TMS stimulation treatment
First Posted Date
2023-04-07
Last Posted Date
2023-05-03
Lead Sponsor
Beijing Neurosurgical Institute
Target Recruit Count
64
Registration Number
NCT05803057
Locations
🇨🇳

Beijing Neurosurgical Institute and Beijing Tiantan Hospital, Beijing, Beijing, China

High-frequency nrTMS on the Contralateral Broca Mirror Area for Glioma Patients With Early Postoperative Aphasia

Not Applicable
Not yet recruiting
Conditions
Glioma
Non-fluent Aphasia
Interventions
Device: nrTMS sham
Device: nrTMS treatment
First Posted Date
2023-03-28
Last Posted Date
2023-03-28
Lead Sponsor
Beijing Neurosurgical Institute
Target Recruit Count
48
Registration Number
NCT05788445

Study on the Prognostic Prediction Model of Patients With Acute Intracerebral Hemorrhage by Artificial Intelligence

Recruiting
Conditions
Cerebral Hemorrhage
Artificial Intelligence
Prognosis
Interventions
Other: Functional outcome follow-up of patients
First Posted Date
2022-06-21
Last Posted Date
2022-06-21
Lead Sponsor
Beijing Neurosurgical Institute
Target Recruit Count
150
Registration Number
NCT05424614
Locations
🇨🇳

Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, China

ZOOMit-fMRI Identifies Language Functional Cortex

Conditions
Glioma
First Posted Date
2022-01-12
Last Posted Date
2022-01-12
Lead Sponsor
Beijing Neurosurgical Institute
Target Recruit Count
60
Registration Number
NCT05188534
Locations
🇨🇳

Beijing Neurosurgical Institute and Beijing Tiantan Hospital, Beijing, Beijing, China

Strategic Intervention on Preserving Motor Function During Awake Craniotomy

Not Applicable
Conditions
Glioma
Interventions
Procedure: Awake craniotomy
First Posted Date
2021-12-03
Last Posted Date
2021-12-20
Lead Sponsor
Beijing Neurosurgical Institute
Target Recruit Count
60
Registration Number
NCT05143788

Strategic Intervention on Preserving Language Function During Awake Craniotomy

Not Applicable
Conditions
Glioma
Interventions
Procedure: Awake craniotomy
First Posted Date
2021-12-03
Last Posted Date
2022-01-03
Lead Sponsor
Beijing Neurosurgical Institute
Target Recruit Count
60
Registration Number
NCT05143775
Locations
🇨🇳

Beijing Neurosurgical Institute and Beijing Tiantan Hospital, Beijing, Beijing, China

Atorvastatin in the TREATment of Intracranial Unruptured VertebroBasilar Dissecting Aneurysms

Not Applicable
Conditions
Dissecting Aneurysm of Cerebral Artery
Inflammation Vascular
Intramural Hematomas
Interventions
First Posted Date
2021-06-29
Last Posted Date
2022-04-06
Lead Sponsor
Beijing Neurosurgical Institute
Target Recruit Count
40
Registration Number
NCT04943783
Locations
🇨🇳

Mirzat Turhon, Beijing, China

🇨🇳

Beijing Neurosurgical Institute and Beijing Tiantan Hospital, Beijing, Beijing, China

Transcranial Magnetic Stimulation in the Rehabilitation of Postoperative Motor Dysfunction.

Not Applicable
Conditions
Postoperative Motor Deficit
Glioma
Interventions
Device: TMS treatment
First Posted Date
2021-01-12
Last Posted Date
2021-01-14
Lead Sponsor
Beijing Neurosurgical Institute
Target Recruit Count
30
Registration Number
NCT04706338
Locations
🇨🇳

Beijing Neurosurgical Institute and Beijing Tiantan Hospital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath